AI Article Synopsis
- * Among 191 patients, the agreement between QFT-G and TST results was only 68.5%, indicating a discrepancy in their diagnostic performance.
- * The findings revealed that while QFT-G showed better positivity in patients with active tuberculosis (85.1% vs. 74% for TST), the overall alignment between the two tests was low, especially with cases that were TST-positive but QFT-negative.
Article Abstract
Background And Objective: Although QuantiFERON-TB Gold (QFT-G) has been approved for the diagnosis of latent tuberculosis infection (LTBI), there are limited data regarding its performance in routine clinical practice. The aim of this study was to compare QFT-G 'In Tube' results, based on stimulation with Mycobacterium tuberculosis-specific antigens, with tuberculin skin test (TST) results in an unselected hospital-based Greek population.
Methods: This was a prospective study of inpatients and outpatients in the University Hospital of Larissa, Greece. Demographic, clinical and microbiological data were collected and correlated to the QFT-G 'In Tube' results. Agreement was tested using the Q-test; kappa coefficient and confounding factors were adjusted for by univariate and multivariable logistic regression.
Results: Among the 191 patients with valid results for both tests, the concordance between the TST and the QFT-G was 68.5%, with a kappa value of 0.38 (95% CI 0.2-0.5). In 27 (14.1%) patients with active tuberculosis, QFT-G 'In Tube' yielded 85.1% positive results compared with 74% for the TST (P = 0.45).
Conclusions: Overall agreement between the QFT-G 'In Tube' assay and the TST in this unselected hospital population was low, mainly due to discordant TST-positive/QFT-negative results.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1440-1843.2007.01188.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Diagnostic Utility of QuantiFERON-Gold Testing in Patients with Ocular Inflammation in a Low-Endemic Tuberculosis Region.
Am J Ophthalmol
August 2024
From the Department of Ophthalmology, University of Colorado School of Medicine, Aurora, Colorado, USA. Electronic address:
Purpose: To evaluate the diagnostic value of QuantiFERON Gold (QFT-G) testing for ocular inflammation in a low prevalence tuberculosis (TB) area.
Design: Diagnostic utility analysis.
Methods: A review was performed for all uveitis patients who underwent QFT-G testing at the University of Colorado Eye Center from 2009 to 2022.
Performance of Interferon-γ Release Assays in Patients with Infection.
Infect Drug Resist
December 2022
Shandong Key Laboratory of Infectious Respiratory Disease, Jinan, People's Republic of China.
Objective: To evaluate the performance of interferon-γ release assays (IGRAs) in patients with infection.
Methods: Consecutive patients between May 2012 and June 2021 who had positive for mycobacterial cultures and who underwent IGRAs (T-SPOT.TB or QuantiFERON-TB Gold [QFT-G]) were included in the analysis.
Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa.
JAAD Case Rep
November 2022
College of Medicine, SUNY Downstate Health Sciences University, Brooklyn, New York.
Agreement between the results of tuberculin skin test and Interferon-Gamma Release Assays in renal transplant candidates.
J Res Med Sci
October 2021
Department of Nephrology, Shahid Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Introduction: Identification of latent tuberculosis (TB) infection is important in kidney transplant candidates. Due to the absence of a gold standard, both tuberculin skin test (TST) and interferon-gamma release assays (IGRA) are used to screen patients. The aim of this study was to evaluate the agreement of these two tests in patients undergoing renal transplantation.
View Article and Find Full Text PDFThe Association between QuantiFERON-TB Gold Test and Clinical Manifestations of Uveitis in the United States.
Am J Ophthalmol
October 2021
From the National Eye Institute, National Institutes of Health, Bethesda, MD (M.Y, N.K, S.K.C, S.C, H.N.S). Electronic address:
Purpose: To report the prevalence of QuantiFERON-TB Gold (QFT-G) positivity among uveitis patients compared to general population and to evaluate the differences in clinical features of uveitis.
Design: Retrospective cohort study.
Methods: SETTING: Institutional.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!